Q32 Bio Inc.QTTBNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank44
3Y CAGR-58.8%
5Y CAGR-66.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-58.8%/yr
vs -45.1%/yr prior
5Y CAGR
-66.9%/yr
Recent acceleration
Acceleration
-13.7pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.76 | - |
| 2024 | 0.00 | +100.0% |
| 2023 | -5.29 | -148.7% |
| 2022 | 10.87 | +83.6% |
| 2021 | 5.92 | -96.9% |
| 2020 | 191.83 | -63.3% |
| 2019 | 523.31 | +336.2% |
| 2018 | 119.96 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |